Ozempic Pill (Ozempic Tablets): Doses, How to Take It, Cost and the Wegovy Pill

The Ozempic pill is real, and it is the same semaglutide that is in the Ozempic pen, taken as one tablet a day instead of one injection a week. Its FDA name is Ozempic (semaglutide) tablets, sold in 1.5, 4 and 9 mg strengths, and it is approved for adults with type 2 diabetes: to control blood sugar alongside diet and exercise, and, in people at high risk, to make a heart attack, a stroke or a cardiovascular death less likely.^[1] It is not approved for weight loss. The semaglutide pill approved for weight is the Wegovy pill, which goes up to 25 mg.^[2] Ozempic tablets went on sale in US pharmacies on May 4, 2026, at self-pay prices of $149 to $299 a month depending on the dose.^[5]

What Ozempic tablets are

Oral semaglutide is not new. It was sold in the US from 2019 as Rybelsus in 3, 7 and 14 mg tablets. Novo Nordisk reformulated it so that a larger share of each dose is absorbed, and on February 4, 2026 it announced that the FDA had approved Ozempic tablets as the name for the new 1.5, 4 and 9 mg pills.^[4] The approval rested on a bioequivalence study plus the clinical trials already run on the Rybelsus doses, and Novo says the active ingredient is the same semaglutide molecule.^[4] The new tablets replaced Rybelsus in the US. Our article on whether Rybelsus is being discontinued covers that changeover and the switching rules in detail.

Semaglutide is a peptide, and the gut usually breaks peptides down. The tablet works because it carries an absorption enhancer, SNAC, and because it is absorbed mainly in the stomach.^[1] Even so, very little gets through. The label estimates absolute bioavailability at 1% to 2% for Ozempic tablets, against about 0.4% to 1% for the old Rybelsus tablets, and in a study in healthy volunteers the 1.5, 4 and 9 mg Ozempic tablets produced blood levels with no clinically significant difference from Rybelsus 3, 7 and 14 mg.^[1] That is why the milligram numbers fell while the effect did not.

It also explains the warning printed on the carton: individual strengths of semaglutide are “not substitutable” milligram for milligram.^[1] A 4 mg Ozempic tablet, a 4 mg Wegovy tablet and a 1 mg Ozempic injection are three different products, and the numbers on them cannot be traded across.

What the Ozempic pill is approved for

The label gives two uses, both in adults with type 2 diabetes: improving blood sugar control as an add-on to diet and exercise, and, for people at high risk, lowering the chance of a major cardiovascular event.^[1] The label says the drug has not been shown to be safe and effective in children.^[1] Novo calls it the only FDA-approved oral peptide GLP‑1 for adults with type 2 diabetes.^[5]

The evidence comes from the trials of the original tablets. In PIONEER 1, which randomized 703 adults whose type 2 diabetes was not controlled by diet and exercise alone, HbA1c fell by 1.2 points on 7 mg and 1.4 points on 14 mg over 26 weeks, against 0.3 points on placebo, from a starting level of about 8%.^[12][1] The heart indication rests on SOUL, in which 9,650 adults who had type 2 diabetes and a high cardiovascular risk took 14 mg oral semaglutide or placebo and the tablet cut major cardiovascular events by 14% (hazard ratio 0.86).^[11] Under the label’s own switching table those Rybelsus doses correspond to Ozempic tablets 4 mg and 9 mg.^[1]

Weight is not on the label. People in the diabetes trials did lose some, and Novo’s launch release says people “may also lose weight,” but no Ozempic tablet dose is approved for weight reduction.^[5] What the trials showed on weight is in our review of Rybelsus for weight loss.

Ozempic tablet dosing

The first month is a starting step only, and the label’s medication guide notes that nausea, vomiting and diarrhea are most common when people first start.^[1] The 9 mg tablet is the top dose for now. In February 2026 Novo said it had filed for a 25 mg Ozempic tablet and expected an FDA decision by the end of the year; the current label, posted on DailyMed in August 2026, lists no 25 mg strength.^[4][1]

People on the 0.5 mg Ozempic injection can move to the tablets. The label says to start 4 mg or 9 mg one week after the last injection; it gives no instructions for switching from the 1 mg or 2 mg pens.^[1] For Rybelsus users, 7 mg pairs with the 4 mg Ozempic tablet and 14 mg with 9 mg.^[1] Our Ozempic drug page covers the injection doses.

How to take the Ozempic pill

The tablet only works if it reaches an empty stomach and is left alone there for a while. The label’s rules:^[1]

• Take one tablet each morning while your stomach is empty, with 4 ounces of plain water at most. No coffee, juice or other drinks.
• Swallow it whole, without splitting, crushing, chewing or dissolving it.
• Give it at least 30 minutes before you eat, drink something else or take another pill.
• A missed dose is simply skipped, and the next tablet is taken the following morning. Never take two in one day.
• Keep the tablets in their original bottle until you take them; they need protecting from moisture.

The 30 minutes matter. In the label’s absorption studies, semaglutide levels were higher the longer people waited before eating.^[1] The tablet also slows stomach emptying, which can change how other oral drugs are absorbed. Levothyroxine exposure rose 33% when taken with semaglutide tablets, so people on thyroid medicine or on other drugs that need close monitoring may need extra blood tests.^[1] For people planning a pregnancy, the label says to stop at least two months beforehand because semaglutide takes that long to clear.^[1]

The common side effects are digestive. In the placebo-controlled trials, nausea affected 11% of people on 7 mg and 20% on 14 mg, against 6% on placebo, followed by abdominal pain, diarrhea, decreased appetite, vomiting and constipation.^[1] There is a boxed warning on the label too, about thyroid C‑cell tumors seen in rodents.^[1]

Ozempic pill vs Wegovy pill vs Foundayo

Three GLP‑1 pills are now on the US market. Two are semaglutide from Novo Nordisk; the third, Foundayo, is Eli Lilly’s orforglipron, a different kind of drug altogether.

The Ozempic and Wegovy pills share their three lower strengths and the same morning routine, but they are separate products with separate labels and separate uses.^[1][2] The Wegovy pill climbs to a 25 mg maintenance dose and is licensed for weight reduction in adults who have obesity, or who are overweight with one or more weight-related conditions, and for heart risk in adults with heart disease.^[2] Novo announced its approval on December 22, 2025 as the first oral GLP‑1 for obesity in the US.^[8] The Wegovy label advises against combining it with any other semaglutide product, which rules out taking both pills.^[2] What the weight pill costs is broken down dose by dose in Wegovy pill cost, and how it compares with the weekly shot is in is the pill as good as the shot.

Foundayo is the odd one out. Orforglipron is a synthetic small molecule (its label gives a molecular weight of about 902 g/mol) rather than a peptide, so it does not need an absorption enhancer or an empty stomach: the label says to take it with or without food.^[3] The FDA approved it on April 1, 2026 as a new molecular entity, for weight reduction only.^[9][3] One practical difference cuts the other way. Women who use the pill for contraception are told by its label to use a non-oral method instead, or to add a barrier method, for the 30 days after they start and the 30 days after every dose increase.^[3] Our Foundayo explainer covers its trial results.

What the Ozempic pill costs

At launch Novo set self-pay prices, through NovoCare Pharmacy and some telehealth services, of $149 a month for the 1.5 mg starting dose, $199 for 4 mg and $299 for 9 mg, where a month means a 30-tablet bottle.^[5] In October 2026 NovoCare still listed the Ozempic pill from $149 a month.^[6] The Wegovy pill uses the same ladder through NovoCare: $149 for 1.5 mg, $199 for 4 mg and $299 for both 9 mg and 25 mg.^[2][6] A person on the Wegovy pill’s 25 mg maintenance dose therefore pays the same self-pay price as a person on the 9 mg Ozempic tablet.

With commercial insurance that covers the tablet, Novo’s savings offer brings the cost to $25 or less for a supply of up to three months, with savings capped at $100 a month.^[5][6] Novo’s launch terms exclude government beneficiaries, such as people on Medicare, from these offers.^[5] Because the tablet is licensed for type 2 diabetes, plans generally expect that diagnosis. The list price, before any insurance or discount, is $1,027.51 a bottle at every strength, the same figure Novo lists for each Ozempic pen.^[7]

Foundayo’s self-pay ladder from Lilly starts at $149 for 0.8 mg and reaches $299 at 9 mg; Lilly has cut its 2.5 mg and 5.5 mg prices temporarily through December 31, 2026.^[10] For sellers that list any of the three pills, see our oral GLP‑1 seller table.

Ozempic tablets or the Ozempic pen?

Both contain semaglutide, and Novo lists heart-risk reduction in type 2 diabetes among the uses of each.^[5] The choice is mostly about routine: one injection a week against a daily tablet that has to be taken fasting and followed by a half-hour wait.^[1] The pen also comes in more strengths, up to 2 mg a week.^[7] The side-by-side in Rybelsus vs Ozempic still applies to the tablet, since the trials behind it are the same, and our Rybelsus drug page covers the original oral form.